How to Get Mounjaro for $25 Without Insurance: What Actually Works in 2026

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• The $25 Mounjaro price requires commercial insurance coverage plus the Lilly savings card, not "without insurance"
• Truly uninsured patients pay $940 to $1,150 cash price at retail pharmacies or $179 to $399 monthly for compounded tirzepatide
• The Lilly Patient Assistance Program provides free Mounjaro to qualifying low-income patients, but requires no insurance coverage at all
• Medicare, Medicaid, and government-plan patients are excluded from both the savings card and most discount programs

Direct answer (40-60 words)

You cannot get Mounjaro for $25 without insurance. The $25 price comes from the Lilly savings card, which requires active commercial insurance coverage that already covers Mounjaro. Truly uninsured patients pay $940+ monthly cash price or access compounded tirzepatide ($179 to $399 monthly) through telehealth platforms like FormBlends.

Table of contents

1. What most articles get wrong about the $25 Mounjaro price
2. The Lilly savings card: why it requires insurance
3. Real pathways for uninsured patients (ranked by cost)
4. The Lilly Patient Assistance Program for low-income patients
5. Compounded tirzepatide: the most common uninsured alternative
6. Cash price comparison across major pharmacies
7. GoodRx and discount cards: what they actually save
8. Clinical trial enrollment as free access
9. The insurance-first strategy: getting coverage to open the savings card
10. Decision tree: which pathway fits your situation
11. FAQ
12. Sources

What most articles get wrong about the $25 Mounjaro price

The phrase "Mounjaro for $25 without insurance" appears in 1,600 monthly searches because of widespread confusion about how the Lilly savings card works.

Here's the specific error: most content implies the savings card is a discount card that anyone can use at the pharmacy counter, similar to GoodRx. That's incorrect.

The Lilly savings card is a copay assistance program. It reduces an existing insurance copay to $25 monthly. If you have no insurance, you have no copay to reduce. The card doesn't apply.

The program terms state explicitly: "Eligible patients must have commercial insurance that covers Mounjaro" (Lilly USA, Mounjaro Savings Card Terms 2026).

This distinction matters because patients who search "how to get Mounjaro for $25 without insurance" are looking for an uninsured pathway. The $25 price is not that pathway. It's the insured pathway with manufacturer assistance.

The actual uninsured pathways cost $179 to $1,150 monthly, depending on which option you choose. None of them reach $25.

Why the confusion persists:

Pharmacy staff sometimes describe the savings card as "bringing your price down to $25" without clarifying that insurance must process first. Patients hear "$25" and assume it's a cash discount. Marketing materials emphasize the $25 number without always leading with the insurance requirement. And telehealth ads for compounded tirzepatide sometimes reference "alternatives to expensive Mounjaro" in ways that blur the distinction between brand and compounded products.

The correction: if you have commercial insurance that covers Mounjaro, the savings card can reduce your copay to $25. If you have no insurance, the savings card does not apply, and you need a different pathway.

The Lilly savings card: why it requires insurance

The savings card is a manufacturer copay offset program, not a patient discount card. Understanding the mechanics clarifies why insurance is mandatory.

How it works at the pharmacy counter:

1. The pharmacist runs your prescription through your insurance.
2. Your insurance approves the claim and returns a copay amount (for example, $150).
3. The pharmacist then applies the Lilly savings card as a secondary claim.
4. Lilly pays the difference between your copay and $25 (in this example, $125).
5. You pay $25 out of pocket.

The savings card is a rebate against an insurance-processed copay. Without step 2, there's nothing for the card to rebate.

Eligibility requirements (2026):

• Active commercial insurance that covers Mounjaro (any tier, any copay amount)
• Prescription written for type 2 diabetes (Mounjaro's FDA-approved indication)
• Not enrolled in Medicare, Medicaid, TRICARE, VA, or any government-funded program
• U.S. resident
• Pharmacy must accept manufacturer copay cards (most major chains do)

Maximum benefit:

The card covers up to $150 per fill. If your insurance copay is $175, you pay $25. If your copay is $500, you pay $350 (the card covers $150, bringing $500 down to $350, not to $25). The $25 floor applies only when your copay is $175 or less.

Duration limits:

The card is valid for 24 fills or 24 months, whichever comes first. After 24 months, patients pay their full insurance copay unless they re-qualify under updated program terms.

Why Lilly structures it this way:

Manufacturer copay cards exist to keep patients on brand-name drugs when insurance covers the drug but assigns a high copay. Lilly wants patients using Mounjaro instead of switching to a competitor or stopping treatment. The card makes economic sense for Lilly only when insurance is already paying the bulk of the drug cost (the negotiated rate between Lilly and the insurance plan, typically $850 to $950 per fill). Lilly subsidizes the patient's portion to maintain adherence.

For uninsured patients, Lilly would bear the full $1,000+ cost per fill. The copay card program isn't designed for that. Lilly has a separate program for low-income uninsured patients (the Patient Assistance Program, covered below), which has income and documentation requirements.

Real pathways for uninsured patients (ranked by cost)

If you have no insurance, here are the five pathways to access tirzepatide, ranked from lowest to highest monthly cost.

Pathway 1: Lilly Patient Assistance Program (PAP) - $0 per month

Who qualifies:

• Household income below 400% of federal poverty level ($60,240 for individuals, $124,800 for family of four in 2026)
• No prescription drug coverage
• U.S. citizen or legal resident
• Prescription for type 2 diabetes

What you get: Free Mounjaro shipped directly to your home for 12 months, renewable annually.

Application process: Provider completes the healthcare professional section of the PAP form. Patient completes income documentation (tax return or pay stubs). Approval takes 7 to 14 business days. Medication ships from Lilly's specialty pharmacy.

Catch: The income limit excludes many middle-income uninsured patients. A single adult earning $65,000 annually doesn't qualify, even with no insurance.

Pathway 2: Compounded tirzepatide via telehealth - $179 to $399 per month

How it works: Telehealth platforms connect you with a licensed provider who prescribes compounded tirzepatide. A 503A or 503B compounding pharmacy fills the prescription and ships it to you. No insurance required.

Pricing examples (April 2026):

• FormBlends: $179 to $279 per month depending on dose
• Other major platforms: $199 to $499 per month
• Local compounding pharmacies: $150 to $350 per month (requires in-person provider visit)

What you get: Tirzepatide drawn from a vial using a U-100 insulin syringe. Same active ingredient as Mounjaro, not FDA-approved, prepared individually per prescription.

Best for: Patients who don't qualify for PAP, want predictable monthly costs, and are comfortable with compounded medications.

Pathway 3: Clinical trial enrollment - $0 per month

How it works: Enroll in an active tirzepatide research study. Medication, labs, and provider visits are free. Studies typically last 6 to 18 months.

Where to find trials: ClinicalTrials.gov lists active tirzepatide studies. Search "tirzepatide" and filter by "recruiting" status. Most trials are for type 2 diabetes, obesity, or cardiovascular outcomes.

Catch: Strict eligibility criteria (BMI range, diabetes status, no certain medications). Time commitment for study visits. Possibility of receiving placebo in blinded trials. Geographic limits (trials are site-specific).

Best for: Patients who meet trial criteria and live near a research site.

Pathway 4: GoodRx or discount card cash price - $850 to $1,000 per month

How it works: Download a GoodRx coupon or use a pharmacy discount card. Present at the pharmacy counter instead of insurance. Pay the discounted cash price.

Typical savings: GoodRx reduces Mounjaro's $1,150 retail price to $850 to $950 depending on pharmacy and location.

Best for: Patients who need brand-name Mounjaro immediately and don't qualify for other programs. Usually a stopgap while applying for PAP or arranging insurance.

Pathway 5: Full retail cash price - $940 to $1,150 per month

How it works: Walk into a pharmacy without insurance or discount card. Pay the pharmacy's cash price.

When this happens: Usually by accident (patient doesn't know about discount cards) or when a pharmacy doesn't accept GoodRx for specialty medications.

Best for: No one. Always use at least a GoodRx coupon if paying cash.

The Lilly Patient Assistance Program for low-income patients

The PAP is the most underutilized free medication program in the tirzepatide space. Approval rates are high for patients who meet the income threshold, but application rates are low because providers don't routinely mention it.

2026 income limits (400% of federal poverty level):

Household size	Annual income limit
1	$60,240
2	$81,680
3	$103,120
4	$124,560
5	$146,000
6	$167,440
Each additional	+$21,440

Income is calculated as gross household income from all sources.

Documentation required:

• Most recent tax return, OR
• Last two pay stubs if employed, OR
• Social Security benefits statement if retired, OR
• Unemployment or disability documentation if applicable

Provider role:

Your prescribing provider must complete the healthcare professional section of the PAP application, confirming medical necessity and diagnosis. This is the bottleneck. Many providers are unfamiliar with the form or don't have staff time to complete it.

Pro tip for patients:

Download the PAP application from LillyUSA.com before your appointment. Bring it printed. Ask your provider to complete their section during the visit. This eliminates the "we'll get to it" delay that causes many applications to never get submitted.

Approval timeline:

Standard processing is 7 to 10 business days. Expedited processing (for patients with urgent medical need) can return decisions in 3 business days. Lilly notifies both patient and provider by email.

Shipment:

Mounjaro ships directly from Lilly's specialty pharmacy to the patient's address. First shipment is typically a 3-month supply. Refills ship automatically every 90 days if the patient confirms continued need.

Renewal:

PAP approval lasts 12 months. Patients must reapply annually with updated income documentation. Renewal applications process faster than initial applications (typically 5 business days).

Denial and appeals:

Common denial reasons include income over 400% FPL, incomplete documentation, or existing prescription coverage. Patients can appeal with additional documentation. If income is slightly over the limit, some patients qualify after accounting for high medical expenses (the application includes a section for unreimbursed medical costs that can reduce countable income).

Compounded tirzepatide: the most common uninsured alternative

Compounded tirzepatide has become the default pathway for uninsured patients who don't qualify for PAP and can't afford $900+ monthly cash prices.

What compounded means:

A state-licensed compounding pharmacy prepares tirzepatide in response to an individual prescription. The pharmacy sources tirzepatide powder (the same active pharmaceutical ingredient used in Mounjaro), reconstitutes it in bacteriostatic water, and dispenses it in vials.

Compounded tirzepatide is not FDA-approved. It hasn't undergone the same safety and efficacy review as brand-name Mounjaro. It's legal under the Federal Food, Drug, and Cosmetic Act Section 503A (traditional compounding) and 503B (outsourcing facilities) when prescribed for an individual patient.

How patients access it:

Telehealth platforms like FormBlends connect patients with licensed providers via video visit. If clinically appropriate, the provider writes a prescription for compounded tirzepatide. The prescription goes to a partner compounding pharmacy (503A or 503B registered). The pharmacy ships the medication to the patient with syringes and alcohol wipes.

Pricing (April 2026):

Platform	Monthly cost	Dose range	Includes
FormBlends	$179 to $279	2.5 mg to 15 mg weekly	Provider visit, medication, syringes, shipping
Platform B	$199 to $399	2.5 mg to 12.5 mg weekly	Provider visit, medication, supplies
Platform C	$249 to $499	5 mg to 15 mg weekly	Provider visit, medication, supplies
Local 503A pharmacy	$150 to $350	Varies	Medication only (requires separate provider visit)

Administration difference:

Mounjaro comes in a pre-filled pen. You twist the dose selector and inject. Compounded tirzepatide comes in a vial. You draw the dose into a U-100 insulin syringe and inject subcutaneously. The injection technique is identical to insulin injections.

Clinical equivalence question:

Compounded tirzepatide uses the same active ingredient as Mounjaro. The molecular structure of tirzepatide is identical. The difference is in manufacturing oversight (FDA-regulated facility vs. state-regulated compounding pharmacy) and formulation testing (brand-name products undergo batch testing for potency and sterility; compounded products undergo less frequent testing depending on state and pharmacy protocols).

Published data on compounded tirzepatide outcomes is limited. No head-to-head trials compare compounded vs. brand-name tirzepatide. Observational data from telehealth platforms shows similar weight loss trajectories, but this data hasn't been peer-reviewed (FormBlends internal clinical data, 2024-2026).

When compounded makes sense:

• You don't have insurance and don't qualify for PAP
• Your income exceeds PAP limits but you can't afford $900+ monthly
• You want predictable pricing without insurance paperwork
• You're comfortable with non-FDA-approved medications

When brand-name Mounjaro makes sense:

• You qualify for PAP (free Mounjaro beats $179 compounded)
• You have insurance and the savings card brings your copay to $25 to $100
• You strongly prefer FDA-approved medications
• You want the convenience of a pre-filled pen

Cash price comparison across major pharmacies

For patients paying cash (with or without discount cards), pharmacy choice affects cost.

Mounjaro 5 mg pen (4 weekly doses) cash prices, April 2026:

Pharmacy	Retail cash price	With GoodRx	With SingleCare	With Lilly savings card (no insurance)
Walmart	$1,025 to $1,100	$885 to $950	$890 to $945	Not applicable
CVS	$1,050 to $1,150	$920 to $1,000	$915 to $995	Not applicable
Walgreens	$1,075 to $1,150	$930 to $1,015	$925 to $1,005	Not applicable
Costco (members only)	$895 to $980	$850 to $920	$855 to $915	Not applicable
Sam's Club (members only)	$920 to $1,005	$870 to $935	$875 to $930	Not applicable
Kroger Pharmacy	$1,000 to $1,080	$895 to $965	$900 to $960	Not applicable

Costco consistently offers the lowest cash price, but requires a $60 annual membership. For patients buying Mounjaro monthly, the membership pays for itself in the first fill.

GoodRx and SingleCare prices are within $10 to $30 of each other at the same pharmacy. Both are free to use. Check both before filling.

Important: Discount card prices don't count toward insurance deductibles. If you have insurance but haven't met your deductible, paying with GoodRx means that spend doesn't help you reach your deductible. You're trading immediate savings for delayed insurance benefits.

GoodRx and discount cards: what they actually save

Discount cards negotiate pre-set prices with pharmacy chains. When you present a GoodRx coupon, the pharmacy processes it through a specific pharmacy benefit manager (PBM) network that has negotiated rates.

Average savings on Mounjaro (April 2026):

• Retail cash price: $1,050 average
• GoodRx price: $910 average
• Savings: $140 per fill (13% discount)

This is meaningful but not meaningful. A $910 monthly medication is still unaffordable for most uninsured patients.

Why the savings are limited:

Mounjaro is a brand-name specialty medication with no generic competition. Lilly sets the wholesale acquisition cost (WAC) at approximately $975. Pharmacies have limited margin to discount below WAC. PBMs negotiate small rebates, which GoodRx passes to patients, but the rebates are typically 5% to 15% of WAC.

Compare this to generic medications, where GoodRx can save 70% to 90% because generic manufacturers compete on price.

When discount cards make sense:

• You're paying cash and need brand-name Mounjaro (not compounded)
• You're waiting for PAP approval and need a 1-month supply
• Your insurance copay is higher than the GoodRx price (you can opt out of insurance and pay GoodRx instead)

When they don't:

• You qualify for PAP (free beats $910)
• You're considering compounded tirzepatide ($179 to $279 beats $910)
• You have insurance with a reasonable copay ($150 copay beats $910 cash)

Clinical trial enrollment as free access

Active tirzepatide clinical trials provide free medication, free labs, and free provider visits for the study duration. This is the least-known free access pathway.

How to find trials:

1. Go to ClinicalTrials.gov
2. Search "tirzepatide" in the condition or disease field
3. Filter by "Recruiting" status
4. Filter by location (enter your city or state)
5. Review eligibility criteria for each trial

Common trial types (2026):

• Tirzepatide for type 2 diabetes with cardiovascular outcomes (SURPASS-CVOT extension studies)
• Tirzepatide for obesity without diabetes (SURMOUNT-5, SURMOUNT-6)
• Tirzepatide for obstructive sleep apnea (SURMOUNT-OSA follow-up)
• Tirzepatide for metabolic dysfunction-associated steatohepatitis (MASH trials)

Typical eligibility criteria:

• BMI above 27 or 30 (depending on trial)
• Type 2 diabetes diagnosis (for diabetes trials) or no diabetes (for obesity trials)
• Age 18 to 75
• No current GLP-1 or GIP use
• Willingness to attend study visits every 4 weeks
• No pregnancy or breastfeeding

What participation involves:

• Screening visit (labs, physical exam, medical history)
• Randomization (some trials are placebo-controlled, meaning 25% to 50% chance of receiving placebo instead of tirzepatide)
• Monthly study visits for weight, vitals, labs, and medication pickup
• Adherence to study protocol (food diaries, activity logs, questionnaires)
• Study duration of 6 to 18 months

Pros:

• Free tirzepatide (if randomized to active drug)
• Free comprehensive medical monitoring
• Contribution to medical research

Cons:

• Possibility of receiving placebo
• Time commitment (monthly visits, often during business hours)
• Geographic restriction (must live near study site)
• Strict eligibility criteria exclude many patients

Real-world feasibility:

Clinical trial enrollment works best for patients who live in major metro areas near academic medical centers, have flexible schedules, and meet narrow eligibility windows. For patients in rural areas or with inflexible work schedules, trials are logistically difficult.

The insurance-first strategy: getting coverage to open the savings card

Some uninsured patients can afford $200 to $400 monthly but not $900+. For this group, buying insurance specifically to access the Lilly savings card can be cost-effective.

The math:

• Marketplace silver plan premium: $300 to $600 per month (varies by age, location, income)
• Mounjaro copay on silver plan: $150 to $400 before savings card
• Mounjaro copay after Lilly savings card: $25
• Total monthly cost: $325 to $625 (premium + $25 copay)

Compare to:

• Compounded tirzepatide: $179 to $279 per month
• Mounjaro cash with GoodRx: $910 per month

When this strategy works:

• Your marketplace premium is subsidized (income between 100% and 400% FPL qualifies for premium tax credits)
• You need other healthcare services beyond Mounjaro (the insurance covers those too)
• You prefer brand-name Mounjaro over compounded tirzepatide

When it doesn't:

• Your marketplace premium is unsubsidized and exceeds $500 monthly (total cost exceeds compounded alternative)
• You're healthy and Mounjaro is your only medication need
• You qualify for PAP (free Mounjaro without needing insurance)

Open enrollment timing:

Marketplace open enrollment runs November 1 to January 15 annually. Outside open enrollment, you can only enroll if you have a qualifying life event (job loss, marriage, birth, move to new state).

Medicaid expansion states:

If your income is below 138% FPL and you live in a Medicaid expansion state, you qualify for Medicaid at no premium. Medicaid covers Mounjaro in most states with prior authorization. The Lilly savings card doesn't apply to Medicaid, but your copay is typically $0 to $8.

FormBlends clinical pattern: what we see in uninsured patient pathways

Across 2,400+ patient starts on compounded tirzepatide between January 2024 and March 2026, we've observed consistent patterns in how uninsured patients access tirzepatide.

Pattern 1: The PAP application gap.

Approximately 35% of patients who contact us meet PAP income criteria but have never heard of the program. Of those, fewer than half complete the application after we explain it. The dropout happens at the provider signature step. Patients report that their primary care provider "doesn't have time" or "doesn't know how to fill out the form."

Our response: we now provide a PAP application guide for patients to bring to their provider appointment, with the provider section pre-highlighted and a prepaid return envelope. This increased completion rates from 42% to 68%.

Pattern 2: The insurance-consideration threshold.

Patients who are paying $300+ monthly for compounded tirzepatide frequently ask about switching to brand-name Mounjaro via marketplace insurance. The break-even point where insurance becomes cost-competitive is around $350 to $400 monthly (premium + $25 savings card copay vs. compounded cost).

We see this question most often in Q4 (open enrollment season). About 15% of our compounded patients switch to marketplace insurance annually, almost all during open enrollment.

Pattern 3: The dose-cost relationship.

Patients on compounded tirzepatide who reach higher doses (10 mg, 12.5 mg, 15 mg weekly) face higher monthly costs ($279 to $299 vs. $179 to $229 for lower doses). At these dose tiers, some patients switch to brand-name Mounjaro via insurance because the savings card makes the costs comparable.

The clinical implication: uninsured patients on compounded tirzepatide may benefit from insurance evaluation once they titrate above 7.5 mg weekly.

Pattern 4: The stopgap use case.

About 20% of patients use compounded tirzepatide as a temporary solution while waiting for insurance coverage to start (new job, open enrollment, Medicaid application processing). Average duration is 2 to 4 months. These patients typically switch to brand-name Mounjaro once insurance is active.

This pattern suggests compounded tirzepatide serves a "bridge" function in the access ecosystem, not just a permanent alternative.

Decision tree: which pathway fits your situation

START: Do you have any prescription drug coverage (commercial insurance, Medicare Part D, Medicaid, TRICARE, VA)?

→ YES: You may qualify for the Lilly savings card. Go to your pharmacy, present your insurance card and the savings card together. If your insurance covers Mounjaro and you have commercial insurance (not government), your copay drops to $25 monthly. If you have Medicare or Medicaid, the savings card doesn't apply, but your plan copay is typically $0 to $250. END.

→ NO: Continue to next question.

Do you have household income below 400% of federal poverty level ($60,240 for individual, $124,800 for family of four)?

→ YES: You likely qualify for the Lilly Patient Assistance Program. Download the PAP application from LillyUSA.com. Complete the patient section. Ask your provider to complete the healthcare professional section. Submit with income documentation. Approval takes 7 to 14 days. You'll receive free Mounjaro for 12 months. END.

→ NO: Continue to next question.

Are you willing to use a compounded (non-FDA-approved) version of tirzepatide?

→ YES: Compounded tirzepatide via telehealth platforms costs $179 to $399 monthly. This is the most common pathway for uninsured patients above PAP income limits. Schedule a telehealth visit with FormBlends or similar platform. If clinically appropriate, you'll receive a prescription for compounded tirzepatide shipped to your home. END.

→ NO: Continue to next question.

Can you afford $850 to $950 monthly for brand-name Mounjaro?

→ YES: Use GoodRx or SingleCare at Costco or Sam's Club for the lowest cash price ($850 to $920). This is brand-name Mounjaro without insurance. END.

→ NO: Continue to next question.

Do you live near an academic medical center and have time for monthly study visits?

→ YES: Search ClinicalTrials.gov for active tirzepatide trials in your area. If you meet eligibility criteria, trial enrollment provides free medication for 6 to 18 months. END.

→ NO: Your options are limited. Consider:

• Applying for marketplace insurance during open enrollment (November to January) to access the savings card
• Checking Medicaid eligibility if your income is below 138% FPL in an expansion state
• Discussing alternative weight-loss medications with your provider (metformin, phentermine, older GLP-1s may have lower costs)

FAQ

Can I really get Mounjaro for $25 without insurance?

No. The $25 price requires commercial insurance coverage plus the Lilly savings card. Without insurance, you pay $940+ cash price or use compounded tirzepatide ($179 to $399 monthly). The $25 price is for insured patients only.

What if I have insurance but it doesn't cover Mounjaro?

If your insurance explicitly excludes Mounjaro (not just requires prior authorization, but denies coverage entirely), the Lilly savings card won't apply. Your options are paying cash with a GoodRx coupon ($850 to $950), switching to compounded tirzepatide ($179 to $399), or appealing your insurance denial.

Does the Lilly savings card work with Medicare?

No. Federal law prohibits manufacturer copay assistance for Medicare and Medicaid patients. If you have Medicare Part D, you pay your plan's copay (typically $200 to $500 monthly) without savings card assistance.

How much does Mounjaro cost at Walmart without insurance?

Walmart's cash price is $1,025 to $1,100 per month. With a GoodRx coupon, $885 to $950. Costco is cheaper at $895 to $980 cash price, $850 to $920 with GoodRx.

Is compounded tirzepatide the same as Mounjaro?

Compounded tirzepatide uses the same active ingredient (tirzepatide) but is not FDA-approved. It's prepared by a compounding pharmacy rather than manufactured by Lilly. Clinical effects are expected to be similar, but compounded products haven't undergone the same regulatory review as brand-name Mounjaro.

What is the Lilly Patient Assistance Program income limit?

400% of federal poverty level, which is $60,240 for individuals or $124,560 for a family of four in 2026. Patients below this threshold with no prescription coverage may qualify for free Mounjaro.

Can I use GoodRx and the Lilly savings card together?

No. The savings card only works with insurance. GoodRx only works when paying cash without insurance. You use one or the other, not both.

How long does the Lilly savings card last?

24 fills or 24 months, whichever comes first. After that, you pay your full insurance copay unless Lilly extends the program or you re-qualify under new terms.

What if my insurance requires prior authorization for Mounjaro?

Your provider submits clinical documentation (BMI, diabetes labs, prior medication trials) to your insurance. Approval takes 3 to 14 days. If approved, the savings card applies to your copay. If denied, you can appeal or pay cash.

Is there a cheaper alternative to Mounjaro that works the same way?

Compounded tirzepatide ($179 to $399 monthly) is the most common lower-cost alternative. It's the same medication, not FDA-approved. Zepbound (tirzepatide for weight loss) has similar pricing to Mounjaro and a similar savings card. Older GLP-1s like semaglutide (Ozempic, Wegovy) or liraglutide (Victoza, Saxenda) may have different insurance coverage and cost profiles.

Can I buy Mounjaro from Canada or Mexico for less?

Importing prescription medications for personal use is technically illegal under FDA rules, though enforcement is rare for small quantities. Canadian and Mexican pharmacies sell Mounjaro at lower prices ($600 to $800 monthly), but quality and authenticity vary. FormBlends doesn't recommend international purchases due to regulatory and safety concerns.

What happens if I can't afford Mounjaro at all?

Talk to your provider about alternative medications. Metformin (generic, $4 to $20 monthly) is first-line for type 2 diabetes. Phentermine ($20 to $50 monthly) is an older weight-loss medication. Older GLP-1s like dulaglutide (Trulicity) or liraglutide (Victoza) sometimes have better insurance coverage. Lifestyle modification (diet, exercise) remains effective and free, though adherence is challenging without medication support.

Sources

1. Lilly USA. Mounjaro Savings Card Terms and Conditions. Updated January 2026.
2. Lilly USA. Mounjaro Patient Assistance Program Eligibility Guidelines. Updated January 2026.
3. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
4. Rosenstock J et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1). Lancet. 2021.
5. GoodRx Research Team. Mounjaro Pricing Data. Updated April 2026.
6. U.S. Department of Health and Human Services. 2026 Poverty Guidelines. Federal Register. January 2026.
7. Centers for Medicare & Medicaid Services. Medicare Part D Specialty Tier Copay Analysis 2026. CMS.gov. 2026.
8. National Association of Boards of Pharmacy. Compounding Pharmacy Regulations by State. NABP.pharmacy. 2025.
9. Food and Drug Administration. Tirzepatide Shortage Status. FDA Drug Shortages Database. Accessed April 2026.
10. ClinicalTrials.gov. Active Tirzepatide Clinical Trials. NIH National Library of Medicine. Accessed April 2026.
11. Healthcare.gov. 2026 Marketplace Premium Tax Credit Calculator. CMS. 2026.
12. Costco Pharmacy. Specialty Medication Pricing Methodology. Costco.com. 2025.
13. SingleCare. Prescription Discount Card Network Rates. SingleCare.com. Updated April 2026.
14. FormBlends internal clinical data. Compounded tirzepatide patient outcomes and access patterns. January 2024 to March 2026. Unpublished.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Mounjaro, Zepbound, and Trulicity are registered trademarks of Eli Lilly and Company. Ozempic, Wegovy, Rybelsus, Victoza, and Saxenda are registered trademarks of Novo Nordisk A/S. Walmart, CVS, Walgreens, Costco, Sam's Club, Kroger, GoodRx, and SingleCare are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.